CLLS (Cellectis S.A. American Depositary Shares) Stock Analysis - Community

Cellectis S.A. American Depositary Shares (CLLS) is a publicly traded Healthcare sector company. As of May 21, 2026, CLLS trades at $3.65 with a market cap of $387.35M and a P/E ratio of 0.00. CLLS moved +0.83% today. Year to date, CLLS is -19.38%; over the trailing twelve months it is +137.66%. Its 52-week range spans $1.10 to $5.48. Analyst consensus is buy with an average price target of $9.00. Rallies surfaces CLLS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

How does the Rallies community trade CLLS?

Rallies community data for CLLS shows anonymized retail investor ownership, positioning, sentiment, and portfolio context when enough community data is available.

CLLS Key Metrics

Key financial metrics for CLLS
MetricValue
Price$3.65
Market Cap$387.35M
P/E Ratio0.00
EPS$0.00
Dividend Yield0.00%
52-Week High$5.48
52-Week Low$1.10
Volume11
Avg Volume0
Revenue (TTM)$0
Net Income$0
Gross Margin0.00%

Latest CLLS News

CLLS Analyst Consensus

1 analysts cover CLLS: 0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $9.00.

Common questions about CLLS

How does the Rallies community trade CLLS?
Rallies community data for CLLS shows anonymized retail investor ownership, positioning, sentiment, and portfolio context when enough community data is available.
Does Rallies show retail investor data for CLLS?
Rallies shows anonymized community ownership, retail positioning, sentiment, and portfolio context for CLLS when enough community data is available.
Is CLLS research on Rallies investment advice?
No. Rallies provides research, data, and educational context for CLLS. It does not provide personalized investment advice.
CLLS

CLLS